Literature summary for 1.13.11.59 extracted from

Estrada, A.F.; Maier, D.; Scherzinger, D.; Avalos, J.; Al-Babili, S.
Novel apocarotenoid intermediates in Neurospora crassa mutants imply a new biosynthetic reaction sequence leading to neurosporaxanthin formation (2008), Fungal Genet. Biol., 45, 1497-1505.

Search for more literature for 1.13.11.59

Cloned(Commentary)

Cloned (Comment)	Organism
expression in Escherichia coli	Neurospora crassa

Protein Variants

Protein Variants	Comment	Organism
additional information	expression in 3,4-didehydrolycopene accumulating Escherichia coli leads to apo-4'-lycopenal	Neurospora crassa

Organism

Organism	UniProt	Comment	Textmining
Neurospora crassa	-	-	-

Substrates and Products (Substrate)

Substrates	Comment Substrates	Organism	Products	Comment (Products)	Rev.	Reac.
3,4-didehydrolycopene + O2	Cao2 accepts both cyclic and acyclic carotenals	Neurospora crassa	apo-4'-lycopenal + 3-methylbut-2-enal	-	?

Synonyms

Synonyms	Comment	Organism
Cao2	-	Neurospora crassa

General Information

General Information	Comment	Organism
physiological function	enzyme is involved in the biosynthetic pathway to neurosporaxanthin. First step is the cleavage of 3,4-didehydrolycopene into apo-4'-lycopenal by Cao2, which is then oxidized by YLO-1 to yield apo-4'-lycopenoic acid, the last intermediate in the pathway. The final step is then catalyzed by the cyclase activity of AL-2	Neurospora crassa

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)